Articles
Patient perspectives: Elaine Schattner

Patient perspectives: Elaine Schattner

We interview Elaine Schattner, breast cancer survivor, blogger and nonpracticing physician on what she thinks needs to change in order for patients’ needs to better be met. Elaine Schattner had severe scoliosis as a child and consequently spent a lot of time in doctors’ offices and hospital. She underwent...

Articles
Media perspectives: Rob Wright

Media perspectives: Rob Wright

Rob Wright, from Life Science Leader magazine, shares his unique perspective working within the media industry, after spending more than 17 years working in pharmaceuticals. Once a month we bring you a unique perspective on the media industry – this month it’s the turn of Rob Wright, Chief Editor...

Articles
How much confidence can we place in clinical evidence?

How much confidence can we place in clinical evidence?

Is it so important to reach a 5 sigma level of significance with research findings? Robert Matthews thinks it is and explains the implications on how confident we can be in clinical data if only a 2 sigma level of significance is achieved. Robert Matthews is Visiting Reader in Science at Aston University, Birmingham. He currently focuses on using techniques...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. ESMO26: Tango sees 82% ORR with combo in pancreatic cancer
  2. Roche offers $15bn for strategic-level deal with Hansoh
  3. ESMO26: Moderna, MSD reveal cancer jab data early after leak
  4. Clinical trial setup times fall sharply in UK
  5. Despite US policy changes, drug prices stay stubbornly high

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more